Form 4: enVVeno Medical Corp Director Sanjay Shrivastava Buys Shares in Open Market
SEC Form 4 Filing
Director Sanjay Shrivastava increased his holdings in enVVeno Medical Corp by purchasing 5,400 shares of common stock at $2.90 per share on December 24, 2024.
Summary
- On December 26, 2024, a Form 4 filing was submitted to the SEC regarding Sanjay Shrivastava's transaction in enVVeno Medical Corp [NVNO].
- Sanjay Shrivastava, a director of enVVeno Medical Corp, purchased 5,400 shares of common stock on December 24, 2024.
- The purchase price was $2.90 per share.
- Following the transaction, Shrivastava directly owns 9,288 shares of enVVeno Medical Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC filing related to insider trading. It is common for directors and officers of publicly traded companies to buy or sell shares of their company's stock. These transactions are closely monitored by regulators and investors.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/24/2024 | Sanjay Shrivastava purchased 5,400 shares of common stock at $2.90 per share. |
| 12/26/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.